Journal
JOURNAL OF BIOMOLECULAR NMR
Volume 74, Issue 10-11, Pages 509-519Publisher
SPRINGER
DOI: 10.1007/s10858-020-00330-0
Keywords
NMR; Drug design; Fragment based drug discovery; Small molecule solution conformations; Residual dipolar couplings
Categories
Funding
- Pfizer RD
Ask authors/readers for more resources
Nuclear magnetic resonance (NMR) spectroscopy has evolved into a powerful tool within drug discovery over the last two decades. While traditionally being used by medicinal chemists for small molecule structure elucidation, it can also be a valuable tool for the identification of small molecules that bind to drug targets, for the characterization of target-ligand interactions and for hit-to-lead optimization. Here, we describe how NMR spectroscopy is integrated into the Pfizer drug discovery pipeline and how we utilize this approach to identify and validate initial hits and generate leads.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available